Literature DB >> 12536674

Inhibitors of hepatitis C virus NS3.4A protease: an overdue line of therapy.

Robert B Perni1, Ann D Kwong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12536674     DOI： 10.1016/s0079-6468(08)70072-9

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  4 in total

1.  Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus.

Authors:  Ann D Kwong; Robert S Kauffman; Patricia Hurter; Peter Mueller
Journal:  Nat Biotechnol       Date:  2011-11-08       Impact factor: 54.908

Review 2.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

3.  Combination of a hepatitis C virus NS3-NS4A protease inhibitor and alpha interferon synergistically inhibits viral RNA replication and facilitates viral RNA clearance in replicon cells.

Authors:  Kai Lin; Ann D Kwong; Chao Lin
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Identification of novel small molecules as inhibitors of hepatitis C virus by structure-based virtual screening.

Authors:  Jing Li; Xian Liu; Shanshan Li; Yulan Wang; Nannan Zhou; Cheng Luo; Xiaomin Luo; Mingyue Zheng; Hualiang Jiang; Kaixian Chen
Journal:  Int J Mol Sci       Date:  2013-11-20       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.